Cantitate/Preț
Produs
Total produse
Vezi coșul
Value Creation in the Pharmaceutical Industry – The Critical Path to Innovation de A Schuhmacher

Value Creation in the Pharmaceutical Industry – The Critical Path to Innovation

Autor A Schuhmacher
en Limba Engleză Hardback – 23 feb 2016
Dieses Praktikerbuch ist ein Muss f1/4r Berufseinsteiger und Master-Studenten der Betriebswirtschaft, die sich auf eine berufliche Ttigkeit in der Forschung & Entwicklung bei Pharmaunternehmen und Firmen im Bereich Biotechnologie vorbereiten. Die Herausgeber und Autoren verf1/4gen 1/4ber weitreichende Branchenerfahrung und Erfahrung an einigen der renommiertesten europischen Wirtschaftshochschulen.
Citește tot Restrânge

Preț: 67367 lei

Preț vechi: 78333 lei
-14% Nou

Puncte Express: 1011
Preț estimativ în valută:
12894€ • 13527$ • 10696£

Carte indisponibilă temporar


Wish list
Gift list
Am citit!
Adaugă în listă
Doresc să fiu notificat când acest titlu va fi disponibil:
Trimite
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783527339136
ISBN-10: 3527339132
Pagini: 508
Ilustrații: 150 schwarz-weiße Abbildungen
Dimensiuni: 179 x 262 x 31 mm
Greutate: 1.27 kg
Editura: Wiley Vch
Locul publicării:Weinheim, Germany

Public țintă

Pharmaceutical Industry, Biotechnological Industry, Management Consultants, Laboratory Heads, Medicinal Chemists, Company Libraries, Libraries at Universities

Notă biografică

Prof. Dr. Alexander Schuhmacher is a professor for R&D management, Vice Dean of the Faculty of Applied Chemistry and Senator at Reutlingen University. And he is Director for R&D performance metrics and business model innovation at Bioscience Valuation. Before joining the academic world, he worked 14 years in the pharmaceutical industry in various functions in R&D, such as in R&D portfolio management and strategic planning. He studied biology at the University of Constance (Germany), Pharmaceutical Medicine at Witten-Herdecke University (Germany) and he is also a graduate of the Executive MBA program at the University of St. Gallen (Switzerland). Prof. Dr. Markus Hinder studied medicine at the Universities of Heidelberg, Paris and Zürich and obtained a doctoral degree in pharmacology from Heidelberg University. After graduation he trained in clinical pharmacology, cardiology and emergency medicine. Before joining Novartis he held leadership positions in clinical pharmacology, translational medicine, clinical development, medical affairs and project management. Markus is a professor at Cardiff University/ Hochschule Fresenius, reviewer for several journals and associate editor for the Journal of Translational Medicine. Prof. Dr. Oliver Gassmann is a Professor for technology and innovation management at St. Gallen University, where he chairs the Institute of Technology Management. His teaching activities include several executive MBA programs. He has written or edited 18 books and published more than 300 journal articles on technology and innovation management. Until 2002 he headed the R&D department of Schindler. The main focus of his research lies in open innovation and global innovation processes. He is the 1998 recipient of the RADMA Prize and in 2009 was elected among the top 50 researchers by IAMOT, the International Association for Management of Technology.